Alexis D. Leal
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 21
- Cancer Immunotherapy and Biomarkers 13
- Pancreatic and Hepatic Oncology Research 8
- Colorectal Cancer Surgical Treatments 3
- Pathology and Forensic Medicine top 10%
- Genetic factors in colorectal cancer 12
-
- Cancer Genomics and Diagnostics 9
- Dermatology top 10%
- Chemotherapy-related skin toxicity 5
- Anesthesiology and Pain Medicine top 10%
-
- Nausea and vomiting management 5
- Co-authors
- Pashtoon Murtaza KasiCharles L. LoprinziJoleen M. HubbardHumaid O. Al‐ShamsiSiraj M. AliAlexa B. SchrockJames SunScott Kopetz
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Alexis D. Leal
49 papers receiving 866 citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Oncology 545
- Pathology and Forensic Medicine 188
- Cancer Research 127
- Dermatology 60
- Anesthesiology and Pain Medicine 36
Countries citing papers authored by Alexis D. Leal
This map shows the geographic impact of Alexis D. Leal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexis D. Leal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexis D. Leal more than expected).
Fields of papers citing papers by Alexis D. Leal
This network shows the impact of papers produced by Alexis D. Leal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexis D. Leal. The network helps show where Alexis D. Leal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alexis D. Leal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 4 | |
| 4 | Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trialbreakdown → | 2024 | 124 |
| 5 | 2024 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 12 | |
| 8 | 2023 | 8 | |
| 9 | 2022 | 9 | |
| 10 | 2022 | 21 | |
| 11 | 2021 | 18 | |
| 12 | 2020 | 34 | |
| 13 | 2020 | 2 | |
| 14 | 2018 | 14 | |
| 15 | 2014 | 63 | |
| 16 | 2014 | 26 | |
| 17 | 2013 | 12 | |
| 18 | 2013 | 3 | |
| 19 | 2010 | 9 | |
| 20 | 2010 | 24 |
About Alexis D. Leal
Alexis D. Leal is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research, having authored 57 papers that have together received 888 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (21 papers), Cancer Immunotherapy and Biomarkers (13 papers), Genetic factors in colorectal cancer (12 papers), Cancer Genomics and Diagnostics (9 papers), Pancreatic and Hepatic Oncology Research (8 papers), Nausea and vomiting management (5 papers), Chemotherapy-related skin toxicity (5 papers) and Colorectal Cancer Surgical Treatments (3 papers). The work is most often cited by research in Oncology (545 citations), Pathology and Forensic Medicine (188 citations) and Cancer Research (127 citations). Alexis D. Leal has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Pashtoon Murtaza Kasi, Charles L. Loprinzi, Joleen M. Hubbard, Humaid O. Al‐Shamsi, Siraj M. Ali, Alexa B. Schrock, James Sun, Scott Kopetz, Jesse S. Voss and Jeffrey S. Ross. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.